This study is looking at the safety and effectiveness of a treatment for knee osteoarthritis, a condition causing pain and inflammation in the knee joint. The treatment uses your own cells, specifically StroMed (a cell concentrate from your own fat tissue) and Platelet Rich Plasma (PRP), which are injected directly into the affected knee. Researchers want to see if this treatment can reduce pain and inflammation. You might be able to join if you are between 18 and 90 years old and have osteoarthritis in your knee (grade 2 or more). Success will be measured by changes in your knee pain and function, as reported through questionnaires like the KOOS (Knee Osteoarthritis Outcome Score). The study plans to enroll 4000 patients, but the current status of recruitment is unclear.

Study design

This is an open-label study, meaning both you and your doctors will know which treatment you are receiving. It will initially involve 50 patients, with a larger follow-up sample of 4,000 patients.

What's involved

You would receive injections of StroMed and PRP into your knee. You would also have laboratory tests, periodic interviews, and follow-up MRIs for up to 6 months.

Compensation

Not stated in the trial record.

Follow-up

Your progress will be tracked for up to 6 months after treatment, using MRIs, lab tests, and questionnaires.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.